Uterus Transplantation
exclusive partnership to conduct this

clinical research

Uterine Factor Infertility (UFI) is a condition where a woman cannot carry a pregnancy because she was born without a uterus, or has a dysfunctional uterus (for e.g. from cancer or other disease). At least 100,000 women are estimated to be affected in MENAT by this type of infertility which is the only one lacking a treatment today.

At the Sahlengrenska Academy, the University of Gothenburg and the Sahlgrenska University Hospital in Sweden, a research project has been ongoing since 1999 which aims to provide women with the possibility of having biological children with the aid of a transplanted uterus. The Swedish research team accomplished its first birth in September 2014 and has performed a total of nine uterus transplants that have resulted in five pregnancies and four live births.

Bellevue Medical Center, renowned for its high quality standards, has been chosen by the Swedish team for an exclusive partnership in the Middle East/North Africa & Turkey Region, to conduct this clinical research.

About the procedure

Both women, donor and recipient, will undergo clinical tests to check if all is fine and they can undergo the procedures.

The donor should not be older than 60, and can donate even if having previously given birth via C-Section. The donor can be a family member (mother, maternal or paternal aunt), or a friend.

The recipient, who needs a transplant, but still has viable ovaries, will have eggs retrieved, fertilized in vitro (IVF), and frozen. The transplant will then be done, meaning, the donor will have her uterus retrieved, and transplanted into the patient. The patient needs to take anti-rejection medications in order to accept the uterus. Once the uterus is well implanted and healed, the frozen embryos will be planted and hopefully yield to a healthy pregnancy.

Approximately one year is needed for one to be sure that rejection is not occurring and to ascertain that the patient has reached a stable situation with menstruation and anti-rejection medication. The risk of a miscarriage is greater if one implants an egg prematurely.

After 1 or 2 pregnancies, the uterus will be removed, so that the mother can stop the anti-rejection drugs.

The Team

Professor Mats Brännström,
team leader

Professor of obstetrics & gynecology at the University
of Gothenburg and Senior specialist and Sahlgrenska
University Hospital.

Has the overriding responsibility for the project in uterus
transplantation and is also a doctoral advisor for doctoral
candidates who are participating in the research.
Mats Brännstrom has been clinically active in the field
of gynecological tumor surgery since 1988 and has been
a professor since 2001. Has been involved in research on
uterus transplantation since 1999.

Dr. Randa Akouri

Physician and post-doctoral fellow. Doctoral dissertation in the area of uterus transplantation, where she showed among other things the first living offspring resulting from a uterus transplantation.

Interviews & Reports

MTV Tahkik on UTX at BMC
Uterus Transplantation
NEW Tv report on UTX at BMC
Uterus Transplantation
Futur TV interview
Uterus Transplantation
Future Tv report on UTX at BMC
Uterus Transplantation